Intestinal subepithelial myofibroblasts in inflammatory bowel disease: fibroblast heterogeneity, fibrosis, and therapeutic targeting - Quiz - MDSpire

Intestinal subepithelial myofibroblasts in inflammatory bowel disease: fibroblast heterogeneity, fibrosis, and therapeutic targeting

  • By

  • Fang Li

  • Chao Xu

  • Jun Chen

  • Teng Lei

  • Xigui Tian

  • Yuanling Zhang

  • Guoqing Chen

  • June 24, 2026

  • 0 min

Share

Original Source(s)

Intestinal subepithelial myofibroblasts in inflammatory bowel disease: fibroblast heterogeneity, fibrosis, and therapeutic targeting

  • by Fang Li, Chao Xu, Jun Chen, Teng Lei, Xigui Tian, Yuanling Zhang, Guoqing Chen

  • June 24, 2026

Related Content

The innovation trap: How pharma weaponizes a word to extend monopolies

The role of a multidisciplinary approach in the early and differential diagnosis of inflammatory bowel disease–related spondyloarthritis: insights from a cross-sectional study

The gut-liver-kidney-brain axis in Wilson disease: copper speciation-flux and barrier-mediated organ crosstalk